News
June 6, 2022

Experienced financial executive named Regenstrief Institute CFO

Karen CrowKaren Crow, a veteran financial executive and consultant with more than 30 years of experience, will join the Regenstrief Institute as chief financial officer (CFO) on June 16, 2022.

Crow specializes in the not-for-profit healthcare sector. She has also worked in a variety of other industries including insurance, publishing and social services as well as research. She is a strategic thinker who collaborates to drive short-term and long-term organizational strategies.

Crow is a certified public accountant (CPA) and chartered global management accountant (CGMA) with expertise in strategic planning, finance and accounting operations, design and implementation of management software and business process analysis.

Crow most recently served as vice president of finance with Arbor Research Collaborative for Health in Ann Arbor, Michigan, a position she held for the past seven years. She has been a member of the boards of Friends of the Ann Arbor District Library and SOS Family Services. She earned bachelor’s degrees in accounting and business administration from Illinois State University in Normal, Illinois.

About Regenstrief Institute   Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

Related News

Rachel Patzer, PhD

Factors Affecting Treatment Selection Among Patients With Hidradenitis Suppurativa

Published in JAMA Dermatology. Here is a link to the article.   Regenstrief Institute authors:  Rachel Patzer, PhD, MPH

Thomas Imperiale

Next generation stool DNA test has best detection rate of noninvasive colorectal cancer screening tools

Study of highly sensitive noninvasive test published in New England Journal of Medicine A study of more than 21,000

Rachel Patzer, PhD, MPH and Kalli Koukounas, MPH

JAMA study finds facilities treating poor patients penalized by CMS payment model

Social risk and treatment for end-stage kidney disease A new study of more than 2,000 dialysis facilities randomized to